Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer

MLA

Kaveh Zakeri, et al. “Pathologic Response after Neoadjuvant Chemotherapy Predicts Locoregional Control in Patients with Triple Negative Breast Cancer.” Advances in Radiation Oncology, vol. 2, no. 2, Feb. 2017, pp. 105–09. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....206af0b4fa29aad43a823eb2b7a5b67b&authtype=sso&custid=ns315887.

APA

Kaveh Zakeri, Victor Chen, John P. Einck, Catheryn M. Yashar, S.M. Lu, Erin F. Gillespie, & James D. Murphy. (2017). Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer. Advances in Radiation Oncology, 2(2), 105–109.

Chicago

Kaveh Zakeri, Victor Chen, John P. Einck, Catheryn M. Yashar, S.M. Lu, Erin F. Gillespie, and James D. Murphy. 2017. “Pathologic Response after Neoadjuvant Chemotherapy Predicts Locoregional Control in Patients with Triple Negative Breast Cancer.” Advances in Radiation Oncology 2 (2): 105–9. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....206af0b4fa29aad43a823eb2b7a5b67b&authtype=sso&custid=ns315887.